|
|
|
Volumn 33, Issue 3, 2006, Pages
|
|
Human immunodeficiency virus-1 associated nephropathy (HIVAN): epidemiology, pathogenesis, histology, diagnosis, and medical management.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CAUSE OF DEATH;
CD4 LYMPHOCYTE COUNT;
CHRONIC KIDNEY FAILURE;
DISEASE COURSE;
DRUG COMBINATION;
DRUG MONITORING;
EARLY DIAGNOSIS;
EPIDEMIOLOGY;
HEALTH SURVEY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
INCIDENCE;
METHODOLOGY;
MORBIDITY;
PATIENT REFERRAL;
PRIMARY HEALTH CARE;
REVIEW;
TREATMENT OUTCOME;
UNITED STATES;
VIROLOGY;
VIRUS LOAD;
AIDS-ASSOCIATED NEPHROPATHY;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTI-INFLAMMATORY AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CAUSALITY;
CAUSE OF DEATH;
CD4 LYMPHOCYTE COUNT;
DISEASE PROGRESSION;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
EARLY DIAGNOSIS;
HIV-1;
HUMANS;
INCIDENCE;
KIDNEY FAILURE, CHRONIC;
MORBIDITY;
POPULATION SURVEILLANCE;
PRIMARY HEALTH CARE;
REFERRAL AND CONSULTATION;
TREATMENT OUTCOME;
UNITED STATES;
VIRAL LOAD;
|
|
EID: 33747184823
PISSN: 1526744X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (35)
|
